- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Phenylketonuria (PKU)
- Meeting Date: March 2026
- Public Summary Document (PSD) March 2026 PBAC Meeting - (PDF)
- Public Summary Document (PSD) March 2026 PBAC Meeting - (DOCX)
Glycomacropeptide Formula With Docosahexaenoic Acid And Low Phenylalanine – March 2026
Sachets containing oral powder 40 g, 30 (PKU GMPro Delight)
Last updated
11 March 2026